skyepharma plc fda query likely to delay u s filing for asthma drug asthma products maker skyepharma plc expects to delay filing an application for clearance for its flagship pipeline product asthma treatment flutiform in the u s because of a query about clinical trials from the food and drug administration the company said it "may be necessary to generate additional clinical data " the company said it would need as much as &# million to cover the costs of the additional trials 
